Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Nursing and Midwifery, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
BMC Public Health. 2023 Sep 15;23(1):1794. doi: 10.1186/s12889-023-16685-6.
Domestic violence (DV) prior to, and during pregnancy is associated with increased risks for morbidity and mortality. As pregnant women routinely attend antenatal care this environment can be used to offer support to women experiencing DV. We have developed a video intervention that focuses on the use of behavioral coping strategies, particularly regarding disclosure of DV experiences. The effectiveness of this intervention will be evaluated through a randomized controlled trial (RCT) and a concurrent process evaluation.
All pregnant women between 12-22 weeks of gestation attending routine antenatal care at two tertiary level hospitals in Nepal are invited to participate. DV is measured using the Nepalese version of the Abuse Assessment Screen (N-AAS). Additionally, we measure participants' mental health, use of coping strategies, physical activity, and food security through a Color-coded Audio Computer Assisted Self Interview (C-ACASI). Irrespective of DV status, women are randomized into the intervention or control arm using a computer-generated randomization program. The intervention arm views a short video providing information on DV, safety improving actions women can take with an emphasis on disclosing the violence to a trusted person along with utilizing helplines available in Nepal. The control group watches a video on maintaining a healthy pregnancy and when to seek healthcare. The primary outcome is the proportion of women disclosing their DV status to someone. Secondary outcomes are symptoms of anxiety and depression, coping strategies, the use of safety measures and attitudes towards acceptance of abuse. Follow-up is conducted after 32 weeks of gestation, where both the intervention and control group participants view the intervention video after completing the follow-up questionnaire. Additionally, a mixed methods process evaluation of the intervention will be carried out to explore factors influencing the acceptability of the intervention and the disclosure of DV, including a review of project documents, individual interviews, and focus group discussions with members of the research team, healthcare providers, and participants.
This study will provide evidence on whether pregnant women attending regular antenatal visits can enhance their safety by disclosing their experiences of violence to a trusted person after receiving a video intervention.
The study is registered in ClinicalTrial.gov with identifier NCT05199935.
在怀孕前和怀孕期间发生的家庭暴力(DV)与发病率和死亡率增加有关。由于孕妇定期接受产前保健,因此可以在这种环境中为经历 DV 的妇女提供支持。我们已经开发了一种视频干预措施,重点是使用行为应对策略,特别是关于披露 DV 经历。该干预措施的有效性将通过随机对照试验(RCT)和同时进行的过程评估进行评估。
邀请在尼泊尔两家三级医院接受常规产前保健的 12-22 周妊娠的所有孕妇参加。使用尼泊尔虐待评估屏幕(N-AAS)的版本测量 DV。此外,我们通过彩色音频计算机辅助自我访谈(C-ACASI)测量参与者的心理健康,应对策略的使用,身体活动和粮食安全。无论 DV 状态如何,妇女都使用计算机生成的随机化程序随机分配到干预组或对照组。干预组观看一段关于 DV、女性可以采取的安全改善措施的短视频,重点是向可信赖的人披露暴力行为,并利用尼泊尔提供的求助热线。对照组观看关于保持健康怀孕和何时寻求医疗保健的视频。主要结果是向他人披露 DV 状况的妇女比例。次要结果是焦虑和抑郁症状,应对策略,安全措施的使用以及对接受虐待的态度。在妊娠 32 周后进行随访,干预组和对照组参与者在完成随访问卷后观看干预视频。此外,还将对干预措施进行混合方法的过程评估,以探讨影响干预措施接受度和 DV 披露的因素,包括对项目文件的审查,对研究团队成员,医疗保健提供者和参与者的个人访谈和焦点小组讨论。
这项研究将提供证据,证明定期接受产前检查的孕妇在接受视频干预后,是否可以通过向可信赖的人披露其暴力经历来提高自己的安全性。
该研究在 ClinicalTrials.gov 注册,标识符为 NCT05199935。